The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis  by Wang, Kuo-Wei et al.
The significance of seizures and other predictive
factors during the acute illness for the long-term
outcome after bacterial meningitis
Kuo-Wei Wang a, Wen-Neng Chang b, Hsueh-Wen Chang c,
Yao-Chung Chuang b, Nai-Wen Tsai b, Hung-Chen Wang a,
Cheng-Hsien Lu b,*
Seizure (2005) 14, 586—592
www.elsevier.com/locate/yseizaDepartment of Neurosurgery, Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung, Taiwan
bDepartment of Neurology, Chang Gung Memorial Hospital-Kaohsiung, 123 Ta Pei Road,
Niao Sung Hsiang, Kaohsiung Hsien, Taiwan
cDepartment of Biological Science, National Sun Yat-Sen University, Kaohsiung, Taiwan







Background: Seizures are important neurological complications of bacterial menin-
gitis, but no information about its epidemiology and the outcomes of seizures after
community-acquired bacterial meningitis (CABM) in an adult population have been
reported.
Aims: To determine the frequency, clinical relevance, subtypes of seizures during the
acute phase of bacterial meningitis, and the long-term outcomes of seizure compli-
cating adult CABM.
Methods: In this 12-year retrospective study, 117 adult patients were identified with
culture-proven CABM. A comparison was made between the clinical data of the
patients with and without seizures during hospitalization.
Results: Thirty-one patients had seizures during CABM, accounting for 27% (31/117)
of the episodes. The time interval between the onset of bacterial meningitis and the
seizures was 1—21 days (mean, 4 days). Furthermore, 80% (25/31) of the episodes
occurred within 24 h of presentation. Ten patients who had seizures progressed to
status epilepticus. At follow-up after completing treatment, 10 patients completely
recovered and were seizure-free, 19 died of meningitis during the acute stage and the
other two progressed to chronic epilepsy.
Conclusion: A log-rank test demonstrated that the long-term outcome of adult CABM
with acute seizures produced worse outcomes than for those who had no seizures,
though no difference was noted between focal and generalized seizures. None of our* Corresponding author. Tel.: +886 7 731 7123x2283; fax: +886 7 790 2684.
E-mail address: chlu99@ms44.url.com.tw (C.-H. Lu).
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Seizures during acute community acquired bacterial meningitis 587Introduction
Seizures are important neurological complications
of bacterial meningitis,4,12 and it is often associated
with poor outcomes.2,4,5,12,21—23 Concerning
research on the outcome of seizures complicating
bacterial meningitis, most clinical studies have
focused on children populations.2,5,21—23 To our
knowledge, no information about its epidemiology
and the outcomes of seizures after community-
acquired bacterial meningitis (CABM) in an adult
population has been reported. Several important
questions remain unanswered, including the propor-
tion of seizures which occur during the course of
acute bacterial meningitis, the causative patho-
gens, subtypes of seizures during the acute phase
of bacterial meningitis, and the long-term outcomes
in these special groups of patients. In this study, we
examine the clinical characteristics of 117 CABM
patients. We chose to study (1) the types of seizures
that occur during acute bacterial meningitis, (2) the
predictive factors strongly associated with seizures
which occur during the course of acute bacterial
meningitis, and (3) the significance of seizures and
other predictive factors during the acute illness for
the long-term outcome after bacterial meningitis.Patients and methods
Over a period of 12 years (1992—2003), 117 adult
patients at Chang Gung Memorial Hospital-Kaoh-
siung (CGMH) were retrospectively identified as
having culture-proven CABM. Among the 117 adult
patients, 31 suffered from seizures secondary to
bacterial meningitis. A comparison was made
between the clinical data of the patients with and
without seizures during hospitalization.
A definite diagnosis of bacterial meningitis
included the following: (1) positive culture of a
bacterial pathogen in one or more cerebrospinal
fluid (CSF) cultures; (2) typical purulent CSF find-
ings including decreased glucose level, increased
lactate and protein concentration, and pleocytosis
with predominant polymorphonuclear cells; and
(3) classic clinical manifestations including fever,
disturbed consciousness, and signs of meningeal
irritation.10,19 Patients were considered to havemixed bacterial meningitis if at least two bacterial
organisms were isolated from the initial CSF cul-
tures.7 Bacterial meningitis is characterized as
either being nosocomial or community-acquired.14
‘‘Community-acquired bacterial meningitis’’ is
defined as bacterial meningitis contracted outside
of a hospital environment. Patients were excluded
from the study if they had any of the following: (1)
history of head trauma with skull fractures or neu-
rosurgical procedures including CSF shunting; (2)
evidence of concomitant chronic meningitis or
encephalitis not due to bacterial pathogens; and
(3) seizure disorders before the episode of bacterial
meningitis.
In our institution, each patient received an initial
brain computed tomographic scan (CT scan) and/or
magnetic resonance imaging (MRI) study and follow-
up contrast-enhanced CT and/or MRI study every 2
weeks before the lumbar puncture procedures dur-
ing the course of acute meningitis. Furthermore,
emergent follow-up CTstudies were also performed
if clinical deterioration was noted, including acute
onset of focal neurological deficits, seizures or sta-
tusepilepticus, andaprogressivedisturbed conscious
state. In this study, ‘‘abnormal neuroimaging find-
ings’’ were defined as newonset cerebral infarctions,
hydrocephalus, subdural empyema or other abnorm-
alities demonstrated by brain CT scan or MRI during
hospitalization. Seizures were classified according to
the guidelines of the International League Against
Epilepsy.8 In this study, the definition of status epi-
lepticus was modified from those of previous
reports.8,18 It was defined as either continuous sei-
zures lasting at least 5 min or two or more discrete
seizures betweenwhich there is incomplete recovery
of consciousness. Late seizures were defined as those
who had one ormore afebrile seizures after complet-
ing the treatment.23
The initial level of consciousness on admission
was classified into two groups: (I) normal con-
sciousness (Glasgow coma scale (GCS) score = 15)
and (II) disturbed consciousness (GCS score < 15).
Leukocytosis is defined as a white blood cell count
greater than 15  109/L of peripheral blood, leu-
kopenia as a white blood cell count of less than
4  109/L and thrombocytopenia as a platelet
count of less than 150  109/L. The criteria for
hyperglycemic hyperosmolar nonketotic state
(HHNK) in this study were defined as follows: (1)patients without seizures in the acute phase of bacterial meningitis developed late
seizures during the follow-up periods. Poor outcome in this study may attribute to
neurological complications such as seizure, hydrocephalus, infection itself, or a
combination of complications.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
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Table 1 Underlying conditions.
Underlying diseases Number of
patientsa
Diabetes mellitus 28
Liver cirrhosis or alcoholism 13





a Twenty-two patients hadmore than one underlying disease.an admission calculated serum osmolarity
350 mOsm/L; (2) serum glucose 33.3 mmol/L;
(3) arterial pH 7.25; and (4) serum ketone body
negative.
In our institution, we did not use prophylactic
antiepileptic drug (AED) therapy for those who did
not have seizures in the acute stage of bacterial
meningitis. The adjunctive use of dexamethasone in
adult bacterial meningitis is also uncommon,
although it would be different for each patient
according to the preference of his/her doctor. Over
the study period, intravenous administration of
penicillin G or vancomycin with one of the third
generation cephalosporins (ceftriaxone, ceftazi-
dime) or cefepime were the initial empiric antibio-
tics used in the treatment of adult patients with
clinical evidence of bacterial meningitis. Further
antibiotic adjustment was guided according to the
results of pathogenic identification and antibiotic
susceptibility tests.
The clinical data, including gender, and clinical
manifestations between two patient groups (with
or without seizures) during acute phase of menin-
gitis, were analyzed by means of the Chi-square
test or Fisher’s exact test. The mean ages between
the two patient groups were analyzed by Student’s
t-test. CSF glucose, total protein, WBC counts, and
glucose ratios at the time of admission between
the two patient groups were analyzed by the Wil-
coxon rank sum test. Stepwise logistic regression
was used to evaluate the relationships between
clinical factors and the presence of seizures, with
adjustments made for other potential confounding
factors. The outpatient department followed some
patients after discharge, with others interviewed
by telephone to identify neurological outcome.
The association between various clinical and
demographic factors and late seizures, and the
survival curve between those who had seizures
and those without were assessed with Kaplan—
Meier plots compared by a log-rank test. All sta-
tistical analyses were conducted using SAS soft-
ware (1990, SAS Statistical Institute, Cary, North
Carolina).
Results
Among these 117 patients with adult community-
acquired spontaneous bacterial meningitis, 31 had
seizures during the acute phase of bacterial menin-
gitis. The 31 patients included 17 males and 14
females. The mean age was 59.96  13.47 years.
Beside bacterial meningitis, 25 patients had one or
more other underlying conditions, while the other
six did not (Table 1).The time interval between the onset of bacterial
meningitis and the seizures was 1—21 days (mean, 4
days). Among these 31 cases, 27 seizures occurred
within 2 weeks after meningitis, while the other four
occurred after 2 weeks of treatment. Furthermore,
91% (25/27) of the former 27 cases occurred within
24 h of presentation. As for the proposed etiologies
of the former 27 cases, 10 were underlying anatomic
pathologies, five were due to HHNK, and the remain-
ing 12 were undetermined. As for the proposed
etiologies of the latter four cases, three were asso-
ciated with underlying anatomic pathologies, and
other one was due to HHNK.
Regarding the seizure subtypes in these 31
patients, 26 had generalized seizures, and the other
five had focal seizures. The former 26 cases included
generalized tonic-clonic seizures in 22 and focal
seizures evolving to generalized tonic-clonic con-
vulsions in the other four. The frequency of seizures
in these 31 cases during the acute phase of bacterial
meningitis is as follows: 18 patients had one episode
of seizures, three patients had two episodes of
seizures, and 10 patients progressed to status epi-
lepticus. Ten cases progressed to status epilepticus,
six of whom died, and the other four completely
recovered and were seizure-free after completing
the treatment for meningitis. Furthermore, no adult
without seizures in the acute phase of bacterial
meningitis developed late seizures during the study
period. Among these 31 cases, every patient had at
least one electroencephalogram (EEG) performed
during the period of acute infection. The EEG read-
ing showed a predominantly unilateral abnormality
in two patients, while in the other 29, the abnorm-
ality was diffuse. The two cases, which showed a
predominantly unilateral abnormality, one had
brain abscess formation, and the remaining one
had subdural empyema formation.
Abnormal neuroimaging findings were deter-
mined in 26% (30/117) of the episodes during hospi-
talization for bacterial meningitis. Of the 30 cases
that showed neuroimaging abnormalities, 12 had
seizures during hospitalization, while the other 18
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Table 2 Causative organisms of adult community-acquired spontaneous bacterial meningitis with or without
seizures.
Causative organisms With seizures N = 31 (12) Without seizures N = 86 (29)
Gram-negative bacilli (N = 70)
Klebsiella pneumoniae 14 (3) 36 (15)
Other Gram-negative bacilli 6a (3) 14 (7)
Streptococcus species (N = 22) 6b (4) 16 (3)
Staphylococcus species (N = 12) 3 (1) 9 (3)
Other pathogens (N = 13) 2c (1) 11 (1)
Values in parentheses indicate number of fatalities.
a These organisms included Pseudomonas aeruginosa (1), Acinetobacter baumannii (1), Chryseobacterium meningosepticum (1),
Vibrio (1), Proteus mirabilis (1), and Escherichia coli (1).
b These organisms included Group D streptococci (1), non-A, B, and D streptococci (1), Group B streptococci (1), Streptococcus
pneumoniae (1), and viridans streptococci (2).
c These organisms included Listeria monocytogenes (1) and mixed infections (1).did not. The abnormal neuroimaging findings in the
12 cases included hydrocephalus in four, pyogenic
brain abscess in four, subdural empyema in one,
cerebral infarction complicating bacterial meningi-
tis in two, and pyogenic brain abscess in one. The
relationship between the findings of neuroimaging
abnormalities and the occurrence of seizures during
acute bacterial meningitis was not significant
( p = 0.052, Chi-square test), and there was also
no difference in the occurrence of late seizures
between those with abnormal neuroimaging findings
during hospitalization and those without abnormal
neuroimaging findings during hospitalization
( p = 0.064, log-rank test).
The pathogens isolated from the CSF cultures in
these 117 patients are listed in Table 2. Regarding
the relationship between the causative pathogens
(Klebsiella (K.) pneumoniae versus other bacterial
pathogens) and seizures we observed a high pre-
valence of seizures, which occurred during the
course of acute bacterial meningitis when the dis-
ease was caused by K. pneumoniae, although the
statistical analysis was not significant ( p = 0.75,
Chi-square test). Regarding the relationship of
the subgroups of causative pathogens (Gram-nega-
tive bacilli, streptococcal species, staphylococcal
species and other pathogens) to the frequency of
seizures during the acute phase of bacterial menin-
gitis (1—3 episodes and presence of status epilepti-
cus), to the type of seizures (tonic-clonic seizure,
focal seizures evolving to tonic-clonic convulsions,
and focal seizure) and to the outcome independent
of the presence of seizures, the statistical analysis
showed the following: (1) there was no relationship
between the subgroups of causative pathogens and
the frequency of seizures during the acute phase of
bacterial meningitis ( p = 0.92, Fisher’s exact test);
(2) there was no relationship between the sub-
groups of causative pathogens and the type ofseizures ( p = 0.102, Fisher’s exact test); and (3)
there is no relationship between the subgroups of
causative pathogens and the outcome controlled
for the presence of seizures ( p = 0.333, Mantel—
Haenszel test).
Comparison of clinical features and laboratory
data between CABM with or without seizures are
listed in Table 3. Statistical analysis of the clinical
manifestations and laboratory data between the
two patient groups revealed the following signifi-
cant findings: disturbed consciousness on admission
(p = 0.0003), mean age (p = 0.017), and the pre-
sence of disseminated intravascular coagulation
(DIC) ( p = 0.04). Variables used in the logistic
regression included disturbed consciousness on
admission, age and the presence of DIC. The results
revealed that after an analysis of all the above-
mentioned variables, only the presence of disturbed
consciousness on admission ( p = 0.003) was inde-
pendently associated with seizure episodes.
Furthermore, a log-rank test revealed that the dif-
ference between the survival curve of those with
seizures during the acute episode and the survival
curve of those without was significant ( p = 0.0011),
although no difference was noted between focal and
generalized seizures during acute bacterial menin-
gitis ( p = 0.691).
The overall mortality rates for those patients who
had seizures and those had had no seizure during
acute bacterial meningitis were 39% (12/31) and
34% (29/86), respectively (Table 2). Mean duration
of follow-up among the other survivors was
5.5  3.7 years for those patients who had acute
seizure and 6.2  3.4 years for those who had no
seizure. Therapeutic outcomes among those who
had acute seizure were as follows: 10 cases com-
pletely recovered and were seizure-free after com-
pleting the treatment, 19 died of meningitis during
the acute course of bacterial meningitis, and the
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Table 3 A comparison of clinical features and laboratory data between adult community-acquired spontaneous





p-Value OR 95% CI
Sex (male/female) 17/14 59/27 0.168 0.556 0.24—1.29
Mean age 59.96  13.47 52.76  14.38 0.017
Clinical features
Fever 24 77 0.126 0.401 0.135—1.191
Disturbed consciousness
on admission
31 58 0.0003 30.69 1.81—519.8
Septic shock 10 19 0.261 1.679 0.676—4.168
DKA/HHNK 6 8 0.194 2.34 0.741—7.393
Hydrocephalus 4 10 1.0 1.126 0.326—3.89
Bacteremia 13 40 0.661 0.831 0.362—1.904
Infectious endocarditis 1 1 0.461 2.833 0.172—46.73
Brain abscesses 6 5 0.065 3.888 1.093—13.83
Subdural empyema 1 1 0.461 2.833 0.172—46.73
Cerebral infarctions 2 4 0.655 1.414 0.246—8.131
Jaundice 2 4 0.655 1.414 0.246—8.131
ARDS or pneumonia 2 6 1.0 0.92 0.176—4.816
Peripheral blood study
Thrombocytopenia 7 19 0.955 1.029 0.384—2.752
DIC 9 11 0.040 2.789 1.025—7.589
White blood cell count
Leukocytosis (>15  109/L) 24 71 0.44 0.423 0.105—1.703a
10, 4  109/L 3 10 0.375 0.059—2.366
Leukopenia (<4  109/L) 4 5
Neuroimaging findings abnormalities 12 18 0.052 2.386 0.98—5.81
CSF parameterb
Glucose (mmol/L) 3.3  3.5 2.4  2.3 0.493
Glucose/blood glucose ratio 0.18  0.18 0.19  0.19 0.588
Total protein (g/L) 1.09  2.82 0.53  1.95 0.151
White cell count (109/L) 14.24  54.14 14.08  79.11 0.449
N: number of cases; OR: odds ratio; CI: confidence interval; ARDS: adult respiratory distress syndrome; DIC: disseminated
intravascular coagulation.
a Relative to leukopenia (<4  109/L).
b Not all patients were tested.other two had one or more afebrile seizures after
completing treatment (late seizures), progressing to
uncontrolled epilepsy. Furthermore, one of these
two patients, whose epilepsy was poorly controlled,
died of status epilepticus 4 months after completing
the treatment for bacterial meningitis.Discussion
Seizures are an important neurological complication
of CABM, and account for 5—28% of the episodes in
other series.4,6,10,16 In our study, it was the third
most common clinical feature of adult CABM, fol-
lowed by fever and disturbed consciousness,
accounting for 27% (31/117) of the episodes.
The occurrence of seizures usually observed
within 24 h of presentation in another study16and our study, accounted for 76 and 80% of the
episodes, respectively. Seizure activity that has a
focal onset is due to either focal cerebral ischemia
or edema, while generalized seizure activity and
status epilepticus are due to fever, metabolic
derangement, spread from a focal onset to a gen-
eralized tonic-clonic convulsion, or toxicity from
antimicrobial agents.26 The proposed etiologies of
our cases were underlying anatomic pathologies,
metabolic derangement or both.
Seizures complicating bacterial meningitis have
been previously shown to have an adverse effect on
mortality and morbidity.4 There are several reasons
that may lead to increased mortality and morbidity
in those who have convulsions, including the fol-
lowing: (1) these patients are older, commonly
associated with underlying medical conditions,
and have more fulminant courses with a higher
Seizures during acute community acquired bacterial meningitis 591prevalence of bacteremia and shock; and (2) later
neurologic morbidity is attributable to hypoxia,
lactic acidosis, IICP, and autonomic dysfunction.
In our study, we demonstrated that the long-term
outcome of adult CABM with seizures during the
acute phase of bacterial meningitis produced worse
outcomes than for those who had no seizures,
though no difference was noted between focal
and generalized seizures.
Our study demonstrated that there was no rela-
tionship between the subgroups of causative patho-
gens (Gram-negative bacilli, streptococcal species,
staphylococcal species and other pathogens) to the
frequency of seizures during the acute phase of
bacterial meningitis (1—3 episodes and presence of
status epilepticus), to the type of seizures (tonic-
clonic seizure, focal seizures evolving to tonic-
clonic convulsions, and focal seizure) and to the
outcome independent of the presence of seizures.
Although K. pneumoniae was the most common
causative pathogen of CABM causing seizures, the
statistical analysis regarding the relationship
between the causative pathogens (K. pneumoniae
versus other bacterial pathogens) and the occur-
rence of seizures in CABM was also not significant.
This may reflect a high prevalence of K. pneumo-
niae as the causative pathogen of CABM in Tai-
wan.11,25 In Taiwan, when CABM occurs in
patients with DM, K. pneumoniaemeningitis should
be considered.15 It has been postulated that hyper-
glycemia may enhance capsule formation and
thereby increase the virulence of Klebsiella
bacilli.24 Six of our 20 diabetic patients who had
seizures during the acute phase of bacterial menin-
gitis progressed to HHNK during the acute phase of
meningitis. Therefore, such complications make
therapy for bacterial meningitis in this special
group of patients more difficult.
Although the adjunctive use of dexamethasone
has been shown to improve the outcome in adults
with Streptococcus (S.) pneumoniaemeningitis,9 in
Taiwan, the adjunctive use of dexamethasone in
adult bacterial meningitis is uncommon because of
the following reasons17: (1) The majority of bacter-
ial meningitis cases result from infection with K.
pneumoniae, rather than S. pneumoniae20; (2) Most
of the patients with K. pneumoniae meningitis are
associated with diabetes mellitus, and the adjunc-
tive use of corticosteroids may increase the risk of
poor blood glucose control in diabetic patients; and
(3) In areas such as Taiwan, where there is an
apparent increase in the prevalence of penicillin
non-susceptible S. pneumoniae and/or penicillin-
resistant S. pneumoniae strains,13 the empirical
antimicrobial agents for S. pneumoniae meningitis
may include a combination of vancomycin andthird-generation cephalosporins. However, the
concomitant administration of corticosteroids
may significantly reduce the penetration of vanco-
mycin into CSF.1
In a study focused on the risk of unprovoked
seizures after meningitis, patients who have been
followed-up for a long period of time have shown3
that increased incidence of unprovoked seizures is
highest during the first 5 years after meningitis,
although it remains elevated over the subsequent
15 years of follow-up. The 20-year risk of develop-
ing unprovoked seizures is 13% for patients with
bacterial meningitis and early seizures and 2.4%
for patients with bacterial meningitis without
early seizures.3 The other study to synthesize
evidence concerning the effect of AEDs for seizure
prevention and to contrast their effectiveness for
provoked versus unprovoked seizures had demon-
strated that effective or promising results predo-
minate for provoked (acute, symptomatic)
seizures, whereas no drug has been shown to be
effective for unprovoked (epileptic) seizures.27
Among the survivors of our study, two of whom
had acute seizure progressed to uncontrolled
epilepsy, whereas none of the other patients with-
out acute seizures developed late seizures during
the study period. Our standard is to administer
AEDs only to those who had seizures in the acute
stage of bacterial meningitis and continue AED
therapy after the meningitis to prevent the devel-
opment of later epilepsy whereas we did not use
prophylactic AED therapy to those who did not
have seizures in the acute stage of bacterial
meningitis. As this is a retrospective study, it
was not possible to assess the effect of prophy-
lactic AEDs after the acute stage of any cerebral
disease to prevent later epilepsy or draw any
conclusions. Therefore, we look forward to more
prospective, randomized, double-blind, multicen-
ter trials of prophylactic AED therapy investiga-
tions to clarify optimal therapy for this specific
group of patients.
In conclusion, seizures are an important neuro-
logical complication of CABM, and poor long-term
outcome has also been found in this special group
of patients. Poor outcome in this study may be
attributed to neurological complications such as
seizure, hydrocephalus, infection itself, or a com-
bination of complications. None of our patients
without seizures in the acute phase of bacterial
meningitis developed late seizures during the fol-
low-up periods. In spite of the high mortality and
morbidity, adequate treatment of metabolic
derangement, aggressive antimicrobial therapy
and seizure control are essential for improving
therapeutic outcomes.
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